Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy? 1997

P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
Urological Associates of Lancaster, Ltd., Pennsylvania, USA.

OBJECTIVE We initiated a prospective study to verify or refute the complications of lymphocele formation and excessive blood loss associated with heparin prophylaxis in pelvic lymphadenectomy and radical prostatectomy. METHODS A prospective study was completed on 579 men undergoing pelvic lymphadenectomy usually in association with radical prostatectomy. Patients were assigned to group 1 (given preoperative and postoperative subcutaneous heparin) and group 2 (no heparin). All patients were evaluated 2 to 3 weeks after surgery with ultrasound for pelvic lymphocele. RESULTS There was no statistically significant difference in the number or size of pelvic lymphoceles or blood loss in group 1 versus group 2. CONCLUSIONS The use of heparin prophylaxis to prevent thromboembolic complications in conjunction with pelvic lymphadenectomy and radical prostatectomy is not associated with increased blood loss or increased rate of lymphocele formation.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008210 Lymphocele Cystic mass containing lymph from diseased lymphatic channels or following surgical trauma or other injury. Cyst, Lymphatic,Lymphatic Cyst,Lymphocoele,Cysts, Lymphatic,Lymphatic Cysts,Lymphoceles,Lymphocoeles
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
May 2013, BJU international,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
October 1994, The Journal of urology,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
January 1986, The Prostate,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
April 1994, The Journal of urology,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
November 2006, European urology,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
June 2023, Journal of robotic surgery,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
February 1977, The Journal of urology,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
July 2007, European urology,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
May 2003, ANZ journal of surgery,
P R Sieber, and F M Rommel, and V E Agusta, and J A Breslin, and L E Harpster, and H W Huffnagle, and C Stahl
January 1992, Urology,
Copied contents to your clipboard!